Drugs from the seas – current status and microbiological implications

By P. Proksch, R. Edrada, R. Ebel. Applied Microbiology and Biotechnology, 2002

608 citations recorded by the source corpus.

Subfields: Biotechnology, Cancer Research, Pharmacology

View Paper: https://www.semanticscholar.org/paper/15925e67e2ce15edba3511f596e13c1e7da8e140

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biotechnology

1. Robert W. Thacker
2. W. Gerwick

In Pharmacology

1. Robert W. Thacker

Citations in the corpus

• Cyanobacteria in Coral Reef Ecosystems: A Review (2012, background): “Microbial symbionts may produce many of the pharmaceutically active compounds isolated from marine sponges [24, 25].”
• Identification of the cellular site of polychlorinated peptide biosynthesis in the marine sponge Dysidea (Lamellodysidea) herbacea and symbiotic cyanobacterium Oscillatoria spongeliae by CARD-FISH analysis (2005, background): “Despite the discovery of numerous biologically active compounds from marine invertebrates, the development of these pharmaceutical leads has been slow ( Proksch et al. 2002 ); however, progress is being made on a major problem—the limited supply of source materials.”